Product image of Metilbetasone (Methylprednisolone Sodium Succinate) supplied by GNH India

Metilbetasone

Active Ingredient:
Methylprednisolone Sodium Succinate
Origin:
EU

Metilbetasone (Methylprednisolone Sodium Succinate)

Methylprednisolone sodium succinate, the active ingredient in Metilbetasone, is a glucocorticoid presented as an injectable solution for intramuscular use. It is employed to manage acute and chronic inflammatory disorders, severe allergic reactions, asthma attacks, rheumatoid arthritis, and certain dermatologic conditions requiring systemic corticosteroid therapy.

GNH India supplies Metilbetasone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Manufacturer / TM Owner

So.Se.Pharm S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metilbetasone, a systemic glucocorticoid, is indicated for several inflammatory and immune‑mediated conditions.

  • Acute inflammatory disorders: rapidly reduces inflammation and immune activation.
  • Allergic reactions: mitigates severe hypersensitivity and anaphylaxis.
  • Asthma exacerbations: improves airway patency and decreases bronchial swelling.
  • Rheumatoid arthritis: suppresses joint inflammation and pain.
  • Dermatologic conditions requiring systemic steroids: controls severe skin inflammation such as psoriasis or eczema.

How It Works

  • Methylprednisolone sodium succinate penetrates cell membranes and binds intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it modulates gene transcription, up‑regulating anti‑inflammatory proteins (e.g., annexin‑1) and down‑regulating pro‑inflammatory cytokines (e.g., IL‑1, TNF‑α). This broad immunosuppressive effect diminishes leukocyte migration, vascular permeability, and mediator release, producing potent anti‑inflammatory and immunomodulatory actions.

Side Effects

Systemic exposure to methylprednisolone sodium succinate can produce a range of adverse reactions.

Common Side Effects

  • Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.
  • Fluid retention: peripheral edema and weight gain.
  • Mood changes: irritability, insomnia, or euphoria.
  • Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain.

Serious or Rare Side Effects

  • Severe infection risk: opportunistic infections due to immunosuppression.
  • Adrenal insufficiency: suppression of endogenous cortisol production.
  • Osteonecrosis: bone tissue death, particularly in weight‑bearing joints.
  • Psychosis or severe mood disorders: hallucinations, depression, or mania.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications.

  • Diabetes management: monitor blood glucose and adjust antidiabetic therapy as needed.
  • Hypertension monitoring: check blood pressure regularly and treat elevations.
  • Infection screening: assess for active infections and consider prophylaxis when appropriate.
  • Tapering requirement: avoid abrupt discontinuation; gradually reduce dose under medical supervision.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methylprednisolone may alter the pharmacokinetics or pharmacodynamics of several co‑administered drugs.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid exposure.
  • Live vaccines: heightened risk of disseminated infection.
  • Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely)

  • NSAIDs: increased gastrointestinal bleeding risk.
  • Diuretics: potential electrolyte disturbances, especially potassium loss.
  • Antidiabetic agents: may require dose reduction due to steroid‑induced hyperglycemia.

Frequently Asked Questions

Metilbetasone is a systemic glucocorticoid indicated for acute and chronic inflammatory disorders, severe allergic reactions, asthma exacerbations, rheumatoid arthritis, and dermatologic conditions that require systemic steroid therapy. It works by suppressing inflammation and modulating immune responses in these disease states.

The active ingredient binds to intracellular glucocorticoid receptors, forming a complex that moves into the cell nucleus. There it regulates gene transcription, increasing anti‑inflammatory proteins and decreasing pro‑inflammatory cytokines, which collectively reduces inflammation and immune activity throughout the body.

Dosing of Metilbetasone is individualized and must be determined by a qualified prescriber based on the specific indication, severity of disease, patient weight, and comorbid conditions. The prescribing information provides guidance, but the exact regimen should be set by the treating clinician.

The safety of methylprednisolone sodium succinate in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the Metilbetasone product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metilbetasone (methylprednisolone sodium succinate) is a synthetic glucocorticoid with a potency comparable to other intermediate‑acting steroids such as prednisone. It offers rapid onset when given intramuscularly and is often chosen for acute flare‑ups where swift anti‑inflammatory action is needed, whereas some alternatives may be oral or have longer half‑lives.

Store Metilbetasone at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly sealed to maintain sterility and potency.

Metilbetasone is supplied as a sterile injectable solution for intramuscular injection. The injection is performed by a qualified healthcare professional using aseptic technique, and the dose volume is determined by the prescribing clinician based on the therapeutic indication.

Serious risks include severe infections due to immunosuppression, adrenal insufficiency from hypothalamic‑pituitary‑adrenal axis suppression, osteonecrosis of bone, and psychiatric disturbances such as psychosis. Patients should be monitored closely for signs of infection, hormonal imbalance, and mood changes during therapy.

Metilbetasone is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation. It should also be avoided in individuals with systemic fungal infections, uncontrolled systemic viral infections, or those receiving live vaccines without appropriate medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone Sodium Succinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT